Ionis Pharmaceuticals, Inc. Increase (Decrease) in Accounts Payable
Ionis Pharmaceuticals, Inc. (IONS) reported Increase (Decrease) in Accounts Payable of $18.58 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $21.68M, a 283.07% increase year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$3.10M.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $13.76M, a 60.93% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$8.81M.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$15.36M, a 196.06% decline from fiscal 2024.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2024 was $15.99M, a 96.95% increase from fiscal 2023.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2023 was $8.12M, a 642.14% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. increase (decrease) in accounts payable for fiscal 2022 was $1.09M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $21.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $18.58M 10-Q · filed 2026-07-29 | $32.34M derived: sum of 3 quarters · filed 2026-07-29 | $23.53M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2026-03-31 | -$3.10M 10-Q · filed 2026-04-29 | $10.66M derived: sum of 2 quarters · filed 2026-04-29 | $1.85M derived: sum of 3 quarters · filed 2026-04-29 | $7.51M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-12-31 | $13.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.95M derived: sum of 2 quarters · filed 2026-02-26 | $10.61M derived: sum of 3 quarters · filed 2026-07-29 | -$15.36M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$8.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$3.15M derived: sum of 2 quarters · filed 2026-07-29 | -$29.12M 10-Q · filed 2025-10-29 | $6.09M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-06-30 | $5.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$20.31M 10-Q · filed 2026-07-29 | $14.90M derived: sum of 3 quarters · filed 2026-07-29 | $12.74M derived: sum of 4 quarters · filed 2026-07-29 | |
| 2025-03-31 | -$25.97M 10-Q · filed 2026-04-29 | $92.00K 10-Q · filed 2025-04-30 | $9.24M derived: sum of 2 quarters · filed 2026-04-29 | $7.09M derived: sum of 3 quarters · filed 2026-04-29 | -$10.04M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $35.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $33.05M derived: sum of 2 quarters · filed 2026-02-26 | $15.93M derived: sum of 3 quarters · filed 2026-02-26 | $15.99M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$19.27M derived: sum of 2 quarters · filed 2025-10-29 | -$19.21M 10-Q · filed 2025-10-29 | $1.37M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$17.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$17.06M 10-Q · filed 2025-07-30 | $3.52M derived: sum of 3 quarters · filed 2026-02-26 | -$14.46M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $59.00K 10-Q · filed 2025-04-30 | -$13.87M 10-Q · filed 2024-05-07 | $20.64M derived: sum of 2 quarters · filed 2026-02-26 | $2.66M derived: sum of 3 quarters · filed 2026-02-26 | $18.47M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $20.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.60M derived: sum of 2 quarters · filed 2026-02-26 | $18.41M derived: sum of 3 quarters · filed 2026-02-26 | $8.12M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$17.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$2.17M derived: sum of 2 quarters · filed 2024-11-06 | -$12.46M 10-Q · filed 2024-11-06 | -$16.98M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-06-30 | $15.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.52M 10-Q · filed 2024-08-01 | $1.00M derived: sum of 3 quarters · filed 2025-02-19 | $9.28M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2023-03-31 | -$10.29M 10-Q · filed 2024-05-07 | -$14.81M derived: sum of 2 quarters · filed 2025-02-19 | -$6.53M derived: sum of 3 quarters · filed 2025-02-19 | -$12.08M derived: sum of 4 quarters · filed 2025-02-19 | |
| 2022-12-31 | -$4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $3.77M derived: sum of 2 quarters · filed 2025-02-19 | -$1.78M derived: sum of 3 quarters · filed 2025-02-19 | $1.09M 10-K · filed 2025-02-19 | |
| 2022-09-30 | $8.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.73M derived: sum of 2 quarters · filed 2023-11-02 | $5.61M 10-Q · filed 2023-11-02 | $10.34M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | -$5.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.67M 10-Q · filed 2023-08-09 | $2.06M derived: sum of 3 quarters · filed 2024-02-21 | -$5.85M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | $2.88M 10-Q · filed 2023-05-03 | $7.62M derived: sum of 2 quarters · filed 2024-02-21 | -$303.00K derived: sum of 3 quarters · filed 2024-02-21 | $6.45M derived: sum of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | $4.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$3.18M derived: sum of 2 quarters · filed 2024-02-21 | $3.57M derived: sum of 3 quarters · filed 2024-02-21 | -$6.00M 10-K · filed 2024-02-21 | |
| 2021-09-30 | -$7.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.17M derived: sum of 2 quarters · filed 2022-11-09 | -$10.74M 10-Q · filed 2022-11-09 | -$2.52M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-06-30 | $6.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.82M 10-Q · filed 2022-08-09 | $5.40M derived: sum of 3 quarters · filed 2023-02-22 | $9.37M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2021-03-31 | -$9.57M 10-Q · filed 2022-05-04 | -$1.35M derived: sum of 2 quarters · filed 2023-02-22 | $2.62M derived: sum of 3 quarters · filed 2023-02-22 | -$12.73M derived: sum of 4 quarters · filed 2023-02-22 | |
| 2020-12-31 | $8.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $12.18M derived: sum of 2 quarters · filed 2023-02-22 | -$3.17M derived: sum of 3 quarters · filed 2023-02-22 | -$2.75M 10-K · filed 2023-02-22 | |
| 2020-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$11.38M derived: sum of 2 quarters · filed 2021-11-03 | -$10.97M 10-Q · filed 2021-11-03 | -$8.55M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$15.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$14.94M 10-Q · filed 2021-08-04 | -$12.52M derived: sum of 3 quarters · filed 2022-02-25 | -$15.18M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $411.00K 10-Q · filed 2021-05-05 | $2.83M derived: sum of 2 quarters · filed 2022-02-25 | $172.00K derived: sum of 3 quarters · filed 2022-02-25 | $1.26M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$239.00K derived: sum of 2 quarters · filed 2022-02-25 | $848.00K derived: sum of 3 quarters · filed 2022-02-25 | -$16.34M 10-K · filed 2022-02-25 | |
| 2019-09-30 | -$2.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$1.57M derived: sum of 2 quarters · filed 2020-11-04 | -$18.76M 10-Q · filed 2020-11-04 | -$5.81M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$16.10M 10-Q · filed 2020-08-05 | -$3.15M derived: sum of 3 quarters · filed 2021-02-24 | -$2.52M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | -$17.19M 10-Q · filed 2020-05-06 | -$4.24M derived: sum of 2 quarters · filed 2021-02-24 | -$3.61M derived: sum of 3 quarters · filed 2021-02-24 | -$4.70M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2018-12-31 | $12.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $13.58M derived: sum of 2 quarters · filed 2021-02-24 | $12.49M derived: sum of 3 quarters · filed 2021-02-24 | -$655.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | $633.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$462.00K derived: sum of 2 quarters · filed 2019-11-06 | -$13.61M 10-Q · filed 2019-11-06 | -$10.12M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$14.24M 10-Q · filed 2019-08-08 | -$10.75M derived: sum of 3 quarters · filed 2020-03-02 | -$2.42M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | -$13.14M 10-Q · filed 2019-05-09 | -$9.65M derived: sum of 2 quarters · filed 2020-03-02 | -$1.33M derived: sum of 3 quarters · filed 2020-03-02 | -$11.83M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $11.81M derived: sum of 2 quarters · filed 2020-03-02 | $1.31M derived: sum of 3 quarters · filed 2020-03-02 | $1.78M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $8.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$2.18M derived: sum of 2 quarters · filed 2018-11-06 | -$1.71M 10-Q · filed 2018-11-06 | $2.82M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$10.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$10.03M 10-Q · filed 2018-08-07 | -$5.51M derived: sum of 3 quarters · filed 2019-03-01 | -$8.27M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $472.00K 10-Q · filed 2018-05-07 | $5.00M derived: sum of 2 quarters · filed 2019-03-01 | $2.23M derived: sum of 3 quarters · filed 2019-03-01 | $1.21M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $1.76M derived: sum of 2 quarters · filed 2019-03-01 | $740.00K derived: sum of 3 quarters · filed 2019-03-01 | -$10.68M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$2.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$3.78M derived: sum of 2 quarters · filed 2017-11-07 | -$15.20M 10-Q · filed 2017-11-07 | -$6.85M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | -$1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$12.44M 10-Q · filed 2017-08-09 | -$4.09M derived: sum of 3 quarters · filed 2018-02-28 | $4.97M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | -$11.42M 10-Q · filed 2017-05-09 | -$3.07M derived: sum of 2 quarters · filed 2018-02-28 | $5.99M derived: sum of 3 quarters · filed 2018-02-28 | $489.00K derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $17.41M derived: sum of 2 quarters · filed 2018-02-28 | $11.91M derived: sum of 3 quarters · filed 2018-02-28 | $9.21M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $9.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $3.56M derived: sum of 2 quarters · filed 2016-11-09 | $862.00K 10-Q · filed 2016-11-09 | $4.27M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$8.20M 10-Q · filed 2016-08-09 | -$4.79M derived: sum of 3 quarters · filed 2017-03-01 | -$5.36M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$2.69M 10-Q · filed 2016-05-05 | $715.00K derived: sum of 2 quarters · filed 2017-03-01 | $138.00K derived: sum of 3 quarters · filed 2017-03-01 | $4.78M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.83M derived: sum of 2 quarters · filed 2017-03-01 | $7.47M derived: sum of 3 quarters · filed 2017-03-01 | $4.82M 10-K · filed 2017-03-01 | |
| 2014-09-30 | -$577.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $4.06M derived: sum of 2 quarters · filed 2015-11-09 | $1.41M 10-Q · filed 2015-11-09 | $3.77M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | $4.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $1.99M 10-Q · filed 2015-08-05 | $4.35M derived: sum of 3 quarters · filed 2016-02-26 | $3.89M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-03-31 | -$2.65M 10-Q · filed 2015-05-05 | -$287.00K derived: sum of 2 quarters · filed 2016-02-26 | -$747.00K derived: sum of 3 quarters · filed 2016-02-26 | $2.99M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2013-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $1.90M derived: sum of 2 quarters · filed 2016-02-26 | $5.63M derived: sum of 3 quarters · filed 2016-02-26 | $66.00K 10-K · filed 2016-02-26 | |
| 2013-09-30 | -$460.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $3.28M derived: sum of 2 quarters · filed 2014-11-07 | -$2.29M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$1.83M 10-Q · filed 2014-08-04 | |||
| 2013-03-31 | -$5.57M 10-Q · filed 2014-05-06 | ||||
| 2012-12-31 | $1.29M 10-K · filed 2015-03-02 | ||||
| 2011-12-31 | $875.00K 10-K · filed 2014-03-03 | ||||
| 2010-12-31 | $1.32M 10-K · filed 2013-02-28 | ||||
| 2009-12-31 | -$3.65M 10-K · filed 2012-02-29 | ||||
| 2008-12-31 | $962.00K 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |